Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Nephron|October 26, 2020
The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving DialysisTobias Bomholt, Thomas Idorn, Filip K Knop, et al.
Renal Failure|May 25, 2026
Complication rates of 16- and 18-gauge needles for native kidney biopsies: a systematic review and proportional meta-analysisMarie Møller, Tue H Andersen, Rikke Borg, et al.
Scientific Reports|July 27, 2021
Faecal biomarkers in type 1 diabetes with and without diabetic nephropathySigne Abitz Winther, Miia Maininki Mannerla, Marie Frimodt-Møller, et al.
The Lancet. Diabetes & Endocrinology|August 8, 2017
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysisKåre I Birkeland, Marit E Jørgensen, Bendix Carstensen, et al.
Diabetes, Obesity & Metabolism|August 4, 2017
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational studyFrederik Persson, Thomas Nyström, Marit E Jørgensen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 3, 2024
Risk factor analysis for a rapid progression of chronic kidney diseaseAnne H S Vestergaard, Simon K Jensen, Uffe Heide-Jørgensen, et al.
Diabetes, Obesity & Metabolism|July 11, 2018
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular riskNienke M A Idzerda, Frederik Persson, Michelle J Pena, et al.
Proteomics|August 15, 2013
Improving peptide relative quantification in MALDI-TOF MS for biomarker assessmentAmaya Albalat, Angelique Stalmach, Vasiliki Bitsika, et al.
Diabetes Care|January 28, 2021
Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER TrialFrederik Persson, Stephen C Bain, Ofri Mosenzon, et al.
Plos One|June 13, 2023
Diabetes treatment for persons with severe mental illness: A registry-based cohort study to explore medication treatment differences for persons with type 2 diabetes with and without severe mental illnessCatrine Bakkedal, Frederik Persson, Margit Kriegbaum, et al.
Pageof 16